Ovid pauses phase 2 plans for ROCK2 inhibitor to mull rival's data
1 day ago · William Blair analysts said Ovid’s plans to add more dose cohorts to the phase 1 study of OV329 as well as press pause on the OV888 phase 2 study were “prudent …
Gilead and Merck Announce Phase 2 Data Showing a Treatment …
Oct 19, 2024 · The proportion of individuals with HIV-1 RNA <50 c/mL at Week 48 by FDA snapshot algorithm (a secondary endpoint), showed that participants who switched to …
AbbVie Provides Update on Phase 2 Results for Emraclidine in …
3 days ago · AbbVie (NYSE: ABBV) today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with …
Phase II Clinical Trials - BioSpace
3 days ago · BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 …
Feb 27, 2024 · Data from a Phase 1 and a Phase 2a trial evaluating VK2735 (dosed subcutaneously) for metabolic disorders demonstrated an encouraging safety and tolerability …
Intellia Presents Positive Results from the Phase 2 Study of NTLA …
Oct 24, 2024 · “The Phase 2 data demonstrated that a majority of patients in the 50 mg arm experienced a complete response — no attacks at all and no further treatment needed — after …
Top ‘Phase 2’ AI infrastructure stocks that are still high-conviction
Oct 11, 2024 · The typical “phase two” AI infrastructure stock is up 27% year-to-date. Analysts said they expect these stocks’ prices to growth due to earnings growth rather than valuation …
Go Inside Season of Discovery Phase 2 - World of Warcraft
Jan 30, 2024 · Blizzard Entertainment. Sit down with World of Warcraft Classic team designers to explore more of what Season of Discovery Phase 2 has in store for you. We will take you …
X4 Pharmaceuticals Announces Positive Results from
2 days ago · The Phase 1b/Phase 2 clinical trial (NCT04154488) is a proof-of-concept, open-label, multicenter study designed to assess oral mavorixafor, with or without injectable G-CSF, …
Phase 2 trial of bezisterim for newly diagnosed Parkinson's advances
2 days ago · The planned Phase 2 SUNRISE-PD clinical trial of oral bezisterim as a first-line, stand-alone treatment for newly diagnosed Parkinson’s disease patients is scheduled to begin …